Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer

Guliz Ozgun · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
circadian-rhythm
advanced bladder cancer, time-of-day administration, chronotherapy, circadian rhythm, enfortumab vedotin and pembrolizumab (ev/p), urothelial cancer, chronoimmunotherapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 891450
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.